|Articles|July 2, 2023
- Pharmaceutical Executive: July 2023
- Volume 43
- Issue 7
Pharmaceutical Executive, July 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive June 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
Crossing the Brain Barrierover 2 years ago
Biotech’s Survival Story: Companies Bear Down for Lean Yearsover 2 years ago
Harnessing AI for Pharma Salesover 2 years ago
Tapping New and Improved Drug Innovations in Asiaover 2 years ago
Drug Shortages Continue to Plague FDA, Manufacturersover 2 years ago
Contrasting Aims Highlight Pharma Reform Pursuitsover 2 years ago
Shifting Macro Trends Offer Hope for Biotech Performance BoostNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
